• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: T2 BIOSYSTEMS, INC T2BACTERIA PANEL; DIRECT BLOOD BACTERIAL NUCLEIC ACID DETECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

T2 BIOSYSTEMS, INC T2BACTERIA PANEL; DIRECT BLOOD BACTERIAL NUCLEIC ACID DETECTION SYSTEM Back to Search Results
Model Number T2BACTERIA PANEL
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/20/2022
Event Type  malfunction  
Event Description
On (b)(6) 2022, a t2 distributor relayed a customer complaint of a clinical false positive result using the t2bacteria panel.
 
Manufacturer Narrative
T2 biosystems' distributor (italy) relayed a customer complaint that the t2bacteria panel resulted in a positive staphylococcus aureus result on a negative clinical sample after being run on t2dx instrument isa3317000134.The customer reported the false positive result as compared to negative blood culture of the same venous collection.Patient details were not provided.Based on the information provided by the distributor, there was no allegation from the institution that the alleged false positive led to an adverse event or patient harm.Specific run data was transferred to t2 biosystems for review and evaluation and a field service engineer (fse) was dispatched to the clinic on (b)(6) 2022; the t2bacteria panel and associated blood samples were discarded after use.Review of the design history records of the associated t2bacteria lot (wo-20570) resulted in no findings related to product quality.Fse observation of the customer's sample preparation methods suggested procedures that deviated from the ifu.T2 biosystems fse advised on best practices for sample handling and instrument maintenance according to the ifu and operator manual.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
T2BACTERIA PANEL
Type of Device
DIRECT BLOOD BACTERIAL NUCLEIC ACID DETECTION SYSTEM
Manufacturer (Section D)
T2 BIOSYSTEMS, INC
101 hartwell avenue
lexington MA 02421
Manufacturer (Section G)
T2 BIOSYSTEMS, INC
101 hartwell avenue
lexington MA 02421
Manufacturer Contact
bill jacques
101 hartwell avenue
lexington, MA 02421
7817614635
MDR Report Key15512060
MDR Text Key306412719
Report Number3010097867-2022-00031
Device Sequence Number1
Product Code QBX
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K172708
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Distributor
Reporter Occupation Other Health Care Professional
Remedial Action Other
Type of Report Initial
Report Date 09/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/30/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/14/2023
Device Model NumberT2BACTERIA PANEL
Device Catalogue Number80-08072
Device Lot NumberWO-20570
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/30/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-